Abbott (ABT) ended the recent trading session at $109.95, demonstrating a +1.78% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 1.01%. Meanwhile, the Dow ...

Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Abbott (ABT). But which of these two stocks presents investors with the ...

Abbott (ABT) ended the recent trading session at $114.12, demonstrating a -1.92% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.04%. Meanwhile, the Dow ...

Abbott Laboratories (NYSE:ABT) is scheduled to announce its second-quarter earnings on Thursday, July 17, 2025. For traders who focus on events, examining the historical reactions of the stock to ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories’ ABT strong sales recovery within the Nutrition business, driven by the robust sales performance of Ensure, is poised to drive growth in the upcoming quarters. The company is ...

Abbott Laboratories (NYSE:ABT) is one of Goldman Sachs top healthcare stocks. On March 10, Abbott Laboratories (NYSE:ABT) ...